Sionna Therapeutics, Inc.

SION · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$20-$18-$16-$16
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$3$3$2$1
Change in WC$2-$2-$2$3
Other Non-Cash-$0-$1-$0-$0
Operating Cash Flow-$15-$18-$16-$12
Investing Activities
PP&E Inv.-$0$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$54-$56-$172-$7
Inv. Sales/Matur.$77$33$30$22
Other Inv. Act.$0$0$0$0
Investing Cash Flow$23-$23-$141$15
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$2-$0$202$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0-$1
Financing Cash Flow$2-$0$202-$1
Forex Effect$0$0$0$0
Net Chg. in Cash$10-$42$45$2
Supplemental Information
Beg. Cash$41$84$39$37
End Cash$51$42$84$39
Free Cash Flow-$15-$18-$16-$12
Sionna Therapeutics, Inc. (SION) Financial Statements & Key Stats | AlphaPilot